PRQR NASDAQ · Healthcare · FY 2025-12-31

ProQR Therapeutics N.V.

Back to NASDAQ
0.00.40.81.21.6ABVfair 0.47buy —EPVnot valid for this companyEBVnot valid for this companyDBVnot valid for this companyprice 1.51 EUR
0.00.50.91.41.9ABVfair 0.53buy —EPVnot valid for this companyEBVnot valid for this companyDBVnot valid for this companyprice 1.72 USD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in EURUSD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Distressed/Deficit
Confidence
●○○ Low · 1/4
Price
1.5111.720 EURUSD *
Market cap
159.1M181.2M EURUSD *
P / B
3.22
P / E
—
EPS
-0.400-0.455
DPS / yield
— (0.0%)
NAV / share
0.4690.534
Graham number
—
Z'' score
-11.22
Piotroski F
1 / 9
Beneish M
—
ROIC vs WACC
— vs 4.8%

* Listed in USD — the pipeline states price and all valuations in the filing currency EUR (fx 0.88 EUR/USD).

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.